BSE filing, NSE: LYNMC. Summary written from the filing by ALFA Finder's alert engine.
Lynx Machinery & Commercials Ltd: key numbers
- Share price
- ₹185.50
- Market cap
- ₹19.02 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-1.55 Cr
- P/E (TTM)
- -11.6×Sector 52.0×
- Promoter holding
- 68.18%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lynx Machinery & Commercials Ltd
All →Lynx Machinery & Commercials Board Meeting Date
Lynx Machinery schedules a board meeting on 6 November 2026 to consider unaudited Q2 results. The trading window stays closed until 9 November 2026.
Lynx Machinery & Commercials Annual General Meeting
Lynx Machinery & Commercials Limited held its 65th Annual General Meeting. Shareholders passed all seven agenda items, including financial adoption and various board and borrowing resolutions.
Lynx Machinery & Commercials Annual General Meeting
Lynx Machinery and Commercials Limited issued the notice for its 65th Annual General Meeting, scheduled for September 29, 2026, including details on e-voting procedures.
Lynx Machinery & Commercials Q1 FY27 Results: Net Loss of ₹0.4 Cr, Loss Widens
Lynx Machinery & Commercials Ltd reported a net loss of ₹0.4 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.4 Cr
Lynx Machinery & Commercials Board Meeting Date
Lynx Machinery & Commercials will hold a board meeting on August 14, 2026, to consider unaudited financial results for the quarter ended June 30, 2026.
Lynx Machinery & Commercials Other Announcement
Lynx Machinery & Commercials Ltd submitted its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulations.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.